Australia vs Gambia: HIV/AIDS deaths averted by antiretroviral therapy
Australia
989.62 deaths
in 2022
Gambia
883.72 deaths
in 2024
Australia rank
74th
Gambia rank
77th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Australia
- Gambia
How they compare
Australia currently reports 989.62 deaths against 883.72 deaths in Gambia, a difference of 105.9 deaths.
That makes Australia's figure about 1.1 times Gambia's.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Gambia ahead.
Australia ranks 74th and Gambia ranks 77th of 157 countries.
Australia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Australia | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 260.07 deaths | 0 deaths | 260.07 deaths | Australia |
| 2000s | 740.59 deaths | 59.36 deaths | 681.23 deaths | Australia |
| 2010s | 840.56 deaths | 595.79 deaths | 244.78 deaths | Australia |
| 2020s | 982.57 deaths | 741.62 deaths | 240.95 deaths | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Australia or Gambia?
- Australia, at 989.62 deaths against 883.72 deaths in Gambia as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Australia and Gambia?
- 105.9 deaths, with Australia ahead.
- How many years of comparable data are there for Australia and Gambia?
- 33 years are reported by both, from 1990 to 2022.
- How do Australia and Gambia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Australia ranks 74th and Gambia ranks 77th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.